Treatments · Entity Annotation Prototype (beta)

1articles mentioning treatments

1treatment mentions

1distinct treatments extracted

0%of mentions human-reviewed

Active filtersEntity: dipeptidyl peptidase-4 inhibitors ×

dipeptidyl peptidase-4 inhibitors

This treatment is selected. Its supporting articles are shown below.

dipeptidyl peptidase-4 inhibitors1

Articles mentioning dipeptidyl peptidase-4 inhibitors

1 articles · page 1 of 1

Enhancing evidence-based care using trial emulation in electronic health records: real-world effects of empagliflozin in people with type 2 diabetes

bmjdrc · abstract · 2026-02-09 · 1 matching annotations

76.7%

dipeptidyl peptidase-4 inhibitors empagliflozin T2DM type 2 diabetes mellitus SGLT2i EMPA-REG RCT

…on. Adults with T2DM initiating empagliflozin (intervention) or dipeptidyl peptidase-4 inhibitors (active control) between January 1, 2014 and December 31, 2022 …

Browse treatments

dipeptidyl peptidase-4 inhibitors

Articles mentioning dipeptidyl peptidase-4 inhibitors

Enhancing evidence-based care using trial emulation in electronic health records: real-world effects of empagliflozin in people with type 2 diabetes